The Mesothelioma Applied Research Foundation (Meso Foundation) announced today that William (Bill) N. Ziegler has been elected to join its board of directors. He will…
Celebrated each November, National Family Caregivers (NFC) Month recognizes and honors the 90 million Americans across the country who selflessly care for family members who…
On Tuesday, November 13, we hosted our Meet the Mesothelioma Experts live broadcast with Dr. Marjorie Zauderer, of Memorial Sloan Kettering Cancer Center and chair…
Valerie W. Rusch, MD, FACS, a respected thoracic surgeon at Memorial Sloan Kettering Cancer Center (MSKCC), was recently elected by her peers to the prestigious…
The National Cancer Institute recently announced that it will be funding a five-year, $10.7 million grant for research into how chimeric antigen receptor (CAR)-T cells…
Shelby Dooley decided to forgo presents for her 8th birthday this fall. Inspired by a classmate who supports a cause for his birthday, she instead…
Earlier this week, we gathered with over 800 rare disease advocates at the 2018 Rare Diseases & Orphan Products Breakthrough Summit hosted in Washington, D.C.…
For the first time in mesothelioma, a group of researchers sequenced the genome of 74 malignant pleural mesothelioma tumors. According to the authors, the study…
Last Friday, October 5, we made our second and final stop on the 2018 International Symposium on Malignant Mesothelioma tour in New York City! Executive…
UPDATE: As of May 2019, the device Optune Lua, formerly known as NovoTTF-100L, was approved by the FDA under the Humanitarian Device Exemption (HDE) in…